Quick Answer
Nuo Therapeutics, Inc. reported Operating Income of -$2.52 million for fiscal year 2025.
Nuo Therapeutics, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$2.52M | -2.4% |
| 2024 | -$2.46M | +22.4% |
| 2023 | -$3.17M | +4.6% |
| 2022 | -$3.32M | -3562.3% |
| 2021 | -$90.7K | +76.0% |
| 2020 | -$378.1K | +61.0% |
| 2019 | -$969.2K | +35.6% |
| 2018 | -$1.50M | +90.3% |
| 2017 | -$15.53M | +62.4% |
| 2015 | -$41.32M | -76.6% |
| 2014 | -$23.39M | -29.3% |
| 2013 | -$18.10M | -40.3% |
| 2012 | -$12.89M | -266.9% |
| 2011 | -$3.51M | +35.0% |
| 2010 | -$5.40M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$540.1K | +6.4% | +17.2% |
| June 30, 2025 | -$652.0K | -20.3% | +12.5% |
| March 31, 2025 | -$745.1K | -5.1% | -29.1% |
| September 30, 2024 | -$577.4K | +26.9% | -6.5% |
| June 30, 2024 | -$542.0K | +37.8% | +23.6% |
| March 31, 2024 | -$709.2K | +17.1% | +10.2% |
| September 30, 2023 | -$789.6K | +13.4% | +9.4% |
| June 30, 2023 | -$871.4K | +5.7% | -1.9% |
- Nuo Therapeutics, Inc. showed a decrease of -2.4% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, Nuo Therapeutics, Inc.’s operating income has grown by 53.4% (from -$5.40 million to -$2.52 million).
- The most recent figure is from Nuo Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: